CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Zhejiang Shouxiangu Pharmaceuticl Co Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Zhejiang Shouxiangu Pharmaceuticl Co Ltd
No. 12 Huanglong 3rd Road, Wuyi County
Phone: +86 57987622285p:+86 57987622285 JINHUA, ZHJ  321200  China Ticker: 603896603896
Business Summary
Zhejiang Shouxiangu Pharmaceutical Co Ltd is a China-based company primarily engaged in the breeding, cultivation, processing, and sales of China-based medicinal herbs. The Company's main products include Shouxiangu brand Ganoderma lucidum spore powder (broken cell wall), Shouxiangu brand broken cell wall Ganoderma lucidum spore powder, Shouxiangu brand broken cell wall Ganoderma lucidum spore powder granules, Shouxiangu brand broken cell wall Ganoderma lucidum spore powder tablets, Shouxiangu brand Dendrobium officinale granules, and Shouxiangu brand Dendrobium officinale and Ganoderma lucidum extract. The Company primarily conducts its businesses in domestic market.
(Source: PROSPECTUS)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
3/31/202612/31/2025Yes----

Industries
SIC Code Description
2833 Medicinal chemicals and botanical products
2834 Pharmaceutical preparations

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Executive Chairman of the Board MingyanLi 65 10/14/2025 5/25/2013
Vice Chairman of the Board ZhenhaoLi 38 4/18/2022 5/25/2013
Finance Director BiaoZhu 51 12/6/2021 12/6/2021
7 additional Officers and Directors records available in full report.

General Information
Number of Employees: 1,119 (As of 12/31/2025)
Outstanding Shares: 198,243,911 (As of 3/31/2026)
Shareholders: 22,035
Stock Exchange: SHA
Fax Number: +86 57987621769


Copyright © 2026 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Wednesday, May 13, 2026